Stanley T. Crooke, Chairman and CEO at IONIS PHARMACEUTICALS INC (IONS), sold 37,000 shares at $61.54 ($2.3M) on 2019-02-26, disclosed to the SEC on 2019-02-27.
Open-market sale of $2.3M IONS by Chairman and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| IONS | SELL | 2020-12-17 | $2.1M | — | Filing → |
| IONS | SELL | 2020-12-09 | $568K | — | Filing → |
| IONS | SELL | 2020-11-30 | $1.3M | — | Filing → |